Expectations rose for Sanofi-Aventis's big new drug hope Acomplia on Friday as the French firm revealed it would present two-year, rather than one-year, data on the anti-obesity medicine next week.
more...
It might be possible to stretch out the scarce U.S. supply of flu vaccine by diluting it and injecting it differently, U.S. researchers said on Wednesday.
more...
A controversial California ballot measure that would fund a decade of stem cell research with $3 billion in state money was headed for a resounding victory on Wednesday, initial returns showed.
more...
Whooping cough is making a comeback 40 years after most industrialized countries started vaccinating children, and the culprit seems to be weakening effects of the shot, researchers said on Saturday.
more...
Novartis AG won U.S. approval to promote the drug Femara for women who have finished standard therapy for early-stage breast cancer and run out of options, the company said on Friday.
more...